18057866

Source:http://linkedlifedata.com/resource/pubmed/id/18057866

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005821, umls-concept:C0009117, umls-concept:C0030705, umls-concept:C0040028, umls-concept:C0051809, umls-concept:C0542341, umls-concept:C1280500
pubmed:issue	4
pubmed:dateCreated	2008-1-30
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0141053
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antithrombin III, http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation..., http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyurea, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Factor 4, http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/anagrelide, http://linkedlifedata.com/resource/pubmed/chemical/antithrombin III-protease complex, http://linkedlifedata.com/resource/pubmed/chemical/fibrin fragment D, http://linkedlifedata.com/resource/pubmed/chemical/prothrombin fragment 1.2
pubmed:status	MEDLINE
pubmed:issn	1421-9662
pubmed:author	pubmed-author:CacciolaEmmaE, pubmed-author:CacciolaRossella RRR, pubmed-author:Di FrancescoErnestoE, pubmed-author:GiustolisiRosarioR, pubmed-author:PezzellaFrancescaF, pubmed-author:TibulloDanieleD
pubmed:issnType	Electronic
pubmed:volume	118
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	215-8
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:18057866-Adult, pubmed-meshheading:18057866-Aged, pubmed-meshheading:18057866-Antithrombin III, pubmed-meshheading:18057866-Aspirin, pubmed-meshheading:18057866-Drug Therapy, Combination, pubmed-meshheading:18057866-Female, pubmed-meshheading:18057866-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:18057866-Hemorrhage, pubmed-meshheading:18057866-Humans, pubmed-meshheading:18057866-Hydroxyurea, pubmed-meshheading:18057866-Male, pubmed-meshheading:18057866-Middle Aged, pubmed-meshheading:18057866-Peptide Fragments, pubmed-meshheading:18057866-Peptide Hydrolases, pubmed-meshheading:18057866-Platelet Activation, pubmed-meshheading:18057866-Platelet Aggregation Inhibitors, pubmed-meshheading:18057866-Platelet Count, pubmed-meshheading:18057866-Platelet Factor 4, pubmed-meshheading:18057866-Prothrombin, pubmed-meshheading:18057866-Quinazolines, pubmed-meshheading:18057866-Thrombocythemia, Essential, pubmed-meshheading:18057866-Thrombosis
pubmed:year	2007
pubmed:articleTitle	Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia.
pubmed:affiliation	Section of Hematology, Department of Biomedical Science, University of Catania, Catania, Italy. rcacciol@unict.it
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial